Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study ID
- NCT00003276
- Phase
- PHASE2
- Status
- Completed
Conditions
- Gallbladder Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- irinotecan hydrochloride — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients with advanced gallbladder or bile duct cancer that cannot be removed surgically.
Key Dates
- Start date
- Mar 31, 1998
- Status verified
- Jul 2016
- Primary completion
- Mar 31, 2001
- Completion
- Mar 31, 2001
Study Design
- Enrollment
- 40 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: irinotecanPatients receive a 90 minute continuous infusion of irinotecan on days 1, 8, 15, and 22 for 4 weeks, followed by a 2 week rest period. Courses of treatment are repeated every 42 days. Patients continue treatment in the absence of disease progression or unacceptable toxicity. Patients are followed every 3 months for 1 year, then every 6 months for the next 4 years.
Primary Outcome Measure
objective tumor response rate [ Time Frame: Up to 5 years ]
Locations (20)
Find similar trials in Scottsdale, AZ
By research site
CCOP - Scottsdale Oncology Program· Scottsdale, AZCCOP - Illinois Oncology Research Association· Peoria, ILCCOP - Carle Cancer Center· Urbana, ILCCOP - Cedar Rapids Oncology Project· Cedar Rapids, IACCOP - Iowa Oncology Research Association· Des Moines, IASiouxland Hematology-Oncology· Sioux City, IA
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract CancerPHASE2 · Recruiting · Case Comprehensive Cancer Center · Cleveland, Ohio
- Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruiting · Cedars-Sinai Medical Center · Los Angeles, California